Published in Protein Sci on April 19, 2012
Optimal translational termination requires C4 lysyl hydroxylation of eRF1. Mol Cell (2014) 0.99
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55
Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR (1999) 26.99
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR (2009) 16.09
Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra. J Magn Reson (1998) 5.83
The crystal structure of human eukaryotic release factor eRF1--mechanism of stop codon recognition and peptidyl-tRNA hydrolysis. Cell (2000) 3.92
Insights into translational termination from the structure of RF2 bound to the ribosome. Science (2008) 3.89
Structural basis for translation termination on the 70S ribosome. Nature (2008) 3.50
A tripeptide 'anticodon' deciphers stop codons in messenger RNA. Nature (2000) 2.90
Crystal structure of a translation termination complex formed with release factor RF2. Proc Natl Acad Sci U S A (2008) 2.33
Termination of translation: interplay of mRNA, rRNAs and release factors? EMBO J (2003) 2.20
Translational termination comes of age. Trends Biochem Sci (2000) 2.10
Terminating eukaryote translation: domain 1 of release factor eRF1 functions in stop codon recognition. RNA (2000) 1.93
The molecular basis of nuclear genetic code change in ciliates. Curr Biol (2001) 1.65
Structural insights into eRF3 and stop codon recognition by eRF1. Genes Dev (2009) 1.57
Highly conserved NIKS tetrapeptide is functionally essential in eukaryotic translation termination factor eRF1. RNA (2002) 1.56
The invariant uridine of stop codons contacts the conserved NIKSR loop of human eRF1 in the ribosome. EMBO J (2002) 1.45
Conversion of omnipotent translation termination factor eRF1 into ciliate-like UGA-only unipotent eRF1. EMBO Rep (2002) 1.40
Omnipotent decoding potential resides in eukaryotic translation termination factor eRF1 of variant-code organisms and is modulated by the interactions of amino acid sequences within domain 1. Proc Natl Acad Sci U S A (2002) 1.28
Class I release factors in ciliates with variant genetic codes. Nucleic Acids Res (2001) 1.27
Invariant amino acids essential for decoding function of polypeptide release factor eRF1. Nucleic Acids Res (2005) 1.24
Convergence and constraint in eukaryotic release factor 1 (eRF1) domain 1: the evolution of stop codon specificity. Nucleic Acids Res (2002) 1.20
Molecular mechanism of stop codon recognition by eRF1: a wobble hypothesis for peptide anticodons. FEBS Lett (2001) 1.12
Distinct paths to stop codon reassignment by the variant-code organisms Tetrahymena and Euplotes. Mol Cell Biol (2006) 1.05
Different modes of stop codon restriction by the Stylonychia and Paramecium eRF1 translation termination factors. Proc Natl Acad Sci U S A (2007) 1.03
Three distinct peptides from the N domain of translation termination factor eRF1 surround stop codon in the ribosome. RNA (2010) 0.96
Stop codons and UGG promote efficient binding of the polypeptide release factor eRF1 to the ribosomal A site. J Mol Biol (2003) 0.93
A single amino acid change of translation termination factor eRF1 switches between bipotent and omnipotent stop-codon specificity. Nucleic Acids Res (2010) 0.93
Molecular recognition and catalysis in translation termination complexes. Trends Biochem Sci (2011) 0.89
Adenine and guanine recognition of stop codon is mediated by different N domain conformations of translation termination factor eRF1. Nucleic Acids Res (2011) 0.87
NMR solution structure and function of the C-terminal domain of eukaryotic class 1 polypeptide chain release factor. FEBS J (2010) 0.86
Functional characterization of polypeptide release factor 1b in the ciliate Euplotes. Biosci Rep (2010) 0.83
Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate. Protein Sci (1999) 0.83
Determination of stereospecific assignments, torsion-angle constraints, and rotamer populations in proteins using the program AngleSearch. J Magn Reson B (1995) 0.82
Backbone (1)H, (13)C and (15)N resonance assignment of the N-terminal domain of human eRF1. J Biomol NMR (2004) 0.78
Validation of a new restraint docking method for solution structure determinations of protein-ligand complexes. J Biomol NMR (1999) 0.77
Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc Natl Acad Sci U S A (2010) 2.56
Positioning of the mRNA stop signal with respect to polypeptide chain release factors and ribosomal proteins in 80S ribosomes. FEBS Lett (2002) 1.06
Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH. J Biomol NMR (2005) 0.99
Suramin and suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum. J Biol Chem (2003) 0.99
Three distinct peptides from the N domain of translation termination factor eRF1 surround stop codon in the ribosome. RNA (2010) 0.96
NMR-based solution structure of the complex of Lactobacillus casei dihydrofolate reductase with trimethoprim and NADPH. J Biomol NMR (2002) 0.93
GTP-dependent structural rearrangement of the eRF1:eRF3 complex and eRF3 sequence motifs essential for PABP binding. Nucleic Acids Res (2009) 0.90
Adenine and guanine recognition of stop codon is mediated by different N domain conformations of translation termination factor eRF1. Nucleic Acids Res (2011) 0.87
Effects of co-operative ligand binding on protein amide NH hydrogen exchange. J Mol Biol (2005) 0.86
The ribosomal A site-bound sense and stop codons are similarly positioned towards the A1823-A1824 dinucleotide of the 18S ribosomal RNA. FEBS Lett (2003) 0.86
NMR solution structure and function of the C-terminal domain of eukaryotic class 1 polypeptide chain release factor. FEBS J (2010) 0.86
New approaches to high-throughput structure characterization of SH3 complexes: the example of Myosin-3 and Myosin-5 SH3 domains from S. cerevisiae. Protein Sci (2006) 0.80
Binding of sucrose octasulphate to the C-type lectin-like domain of the recombinant natural killer cell receptor NKR-P1A observed by NMR spectroscopy. Chembiochem (2002) 0.79
NMR assignments of the C-terminal domain of human polypeptide release factor eRF1. Biomol NMR Assign (2007) 0.78
NMR assignments of the middle domain of human polypeptide release factor eRF1. J Biomol NMR (2006) 0.76
Antimalarial activity of cupredoxins: the interaction of Plasmodium merozoite surface protein 119 (MSP119) and rusticyanin. J Biol Chem (2013) 0.76
The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design. Open Biol (2014) 0.75
Backbone (1)H, (13)C and (15)N resonance assignments of the human eukaryotic release factor eRF1. Biomol NMR Assign (2014) 0.75
The crucial role of conserved intermolecular H-bonds inaccessible to the solvent in formation and stabilization of the TL5.5 SrRNA complex. J Biol Chem (2005) 0.75